Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness and tolerability/safety of
aripiprazole (Abilify) in children with subsyndromal symptoms of bipolar disorder who also
have a parent with bipolar disorder and other family member with a mood disorder.